[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Penumbra Inc (PEN)

Penumbra Inc (PEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Penumbra: Q1 Earnings Snapshot

Penumbra: Q1 Earnings Snapshot

PEN : 322.23 (-0.75%)
Penumbra, Inc. Reports First Quarter 2026 Financial Results

ALAMEDA, Calif. , May 6, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the first quarter ended March 31, 2026.

BSX : 53.93 (-4.67%)
PEN : 322.23 (-0.75%)
Penumbra's First Quarter Without Guidance May Redefine How the Market Values the Acquisition

Barchart Research What to Expect from PEN Earnings PEN Generated May 5, 2026 Current Price $323.86 EPS Estimate $$1.11 Consensus Rating Hold Average Move 8.04% Penumbra's First Quarter Without Guidance...

PEN : 322.23 (-0.75%)
Penumbra's Thrombectomy Momentum: The Quarter Boston Scientific Bet Fourteen Billion Dollars On

Barchart Research What to Expect from PEN Earnings PEN Generated April 28, 2026 Current Price $325.99 EPS Estimate $$1.11 Consensus Rating Hold Average Move 8.04% Penumbra's Thrombectomy Momentum: The...

PEN : 322.23 (-0.75%)
1 Mid-Cap Stock on Our Buy List and 2 We Ignore

1 Mid-Cap Stock on Our Buy List and 2 We Ignore

RBA : 103.28 (-0.15%)
PEN : 322.23 (-0.75%)
FTV : 60.43 (-0.77%)
Are OMEX, PEN, SNCY, CWAN Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

OMEX : 1.2200 (-3.94%)
SNCY : 17.02 (+0.95%)
PEN : 322.23 (-0.75%)
CWAN : 24.35 (+0.21%)
Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Penumbra , Inc....

BSX : 53.93 (-4.67%)
PEN : 322.23 (-0.75%)
Penumbra (NYSE:PEN): Strongest Q4 Results from the Medical Devices & Supplies - Cardiology, Neurology, Vascular Group

Penumbra (NYSE:PEN): Strongest Q4 Results from the Medical Devices & Supplies - Cardiology, Neurology, Vascular Group

PEN : 322.23 (-0.75%)
1 Profitable Stock on Our Buy List and 2 We Brush Off

1 Profitable Stock on Our Buy List and 2 We Brush Off

SHOP : 110.41 (-1.19%)
CWK : 14.19 (+2.45%)
PEN : 322.23 (-0.75%)
Are EHAB, SLAB, PEN, SKYT Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

EHAB : 13.79 (+0.15%)
SKYT : 33.72 (+2.00%)
PEN : 322.23 (-0.75%)
SLAB : 217.45 (-0.09%)

Barchart Exclusives

Palantir Stock Has a ‘High-Class Problem’: Demand for Its Software Is Far Outpacing Supply
Palantir’s greatest challenge may no longer be demand, but how quickly it can deliver AI software to customers. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.